These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6093511

  • 1. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE, Fu KP, Neu HC.
    Am J Med; 1984 Oct 19; 77(4C):112-6. PubMed ID: 6093511
    [Abstract] [Full Text] [Related]

  • 2. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR, Srulevitch ES, Jacobson J, Hirschman SZ.
    Antimicrob Agents Chemother; 1983 Nov 19; 24(5):812-4. PubMed ID: 6318657
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF, Echols RM, Parker MA.
    Clin Pharm; 1985 Nov 19; 4(2):177-81. PubMed ID: 3987216
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH, Kaplan SA.
    Am J Med; 1984 Oct 19; 77(4C):17-25. PubMed ID: 6093513
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of cefotaxime in sheep.
    Guerrini VH, Filippich L, English PB, Bourne DW.
    Am J Vet Res; 1983 Aug 19; 44(8):1488-91. PubMed ID: 6312852
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of cefotaxime in the domestic cat.
    McElroy D, Ravis WR, Clark CH.
    Am J Vet Res; 1986 Jan 19; 47(1):86-8. PubMed ID: 3946912
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H, Kato Y, Kakinoki K, Nishio S, Maekawa M, Tsujita M, Nishijima T, Kashihara N, Kono S, Hayahara N.
    Hinyokika Kiyo; 1983 Jan 19; 29(1):95-103. PubMed ID: 6328956
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K, Adam D.
    Arzneimittelforschung; 1983 Jan 19; 33(3):429-32. PubMed ID: 6683518
    [Abstract] [Full Text] [Related]

  • 17. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M, Grégoire S, Caron M, Bergeron MG.
    Antimicrob Agents Chemother; 1985 Jul 19; 28(1):123-7. PubMed ID: 4037771
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS, Summers KK, Hardin TC.
    Clin Ther; 1999 Nov 19; 21(11):1882-9. PubMed ID: 10890260
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C.
    Chemotherapy; 1985 Nov 19; 31(2):85-94. PubMed ID: 3987394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.